OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quest for a Cure: Potential Small-Molecule Treatments for COVID-19, Part 2
David L. Hughes
Organic Process Research & Development (2021) Vol. 25, Iss. 5, pp. 1089-1111
Open Access | Times Cited: 16

Showing 16 citing articles:

Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19
Mohd Imran, Mandeep Kumar Arora, Syed Mohammed Basheeruddin Asdaq, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 5795-5795
Open Access | Times Cited: 164

Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies
Elisa Souza Vaz, Sandra V. Vassiliades, Jeanine Giarolla, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 6, pp. 723-751
Open Access | Times Cited: 16

Potential Anti-SARS-CoV-2 Prodrugs Activated by Phosphorylation and Their Role in the Aged Population
Vivek P. Chavda, Divya Teli, Pankti C. Balar, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2332-2332
Open Access | Times Cited: 13

Catalytic Regioselective Acylation of Unprotected Nucleosides for Quick Access to COVID and Other Nucleoside Prodrugs
Jie Lv, Juan Zou, Yingling Nong, et al.
ACS Catalysis (2023) Vol. 13, Iss. 14, pp. 9567-9576
Open Access | Times Cited: 11

Photosensitizing Antivirals
Kseniya A. Mariewskaya, Anton P. Tyurin, Alexey A. Chistov, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 3971-3971
Open Access | Times Cited: 26

A path from synthesis to emergency use authorization of molnupiravir as a COVID-19 therapy
Norein Sakander, Ajaz Ahmed, Mahir Bhardwaj, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107379-107379
Closed Access | Times Cited: 3

Evolution of the Synthesis of Remdesivir. Classical Approaches and Most Recent Advances
Didier F. Vargas, Enrique L. Larghi, Teodoro S. Kaufman
ACS Omega (2021) Vol. 6, Iss. 30, pp. 19356-19363
Open Access | Times Cited: 14

Identifying the Hot Spot Residues of the SARS-CoV-2 Main Protease Using MM-PBSA and Multiple Force Fields
Jinyoung Byun, Juyong Lee
Life (2021) Vol. 12, Iss. 1, pp. 54-54
Open Access | Times Cited: 12

Development of a Scalable Lanthanide Halide/Quaternary Ammonium Salt System for the Nucleophilic Addition of Grignard Reagents to Carbonyl Groups and Application to the Synthesis of a Remdesivir Intermediate
Andrew C. Stevens, Katrien Brak, W. Stacy Bremner, et al.
Organic Process Research & Development (2021) Vol. 26, Iss. 3, pp. 754-763
Closed Access | Times Cited: 8

Ditelluride-Catalyzed synthesis of phosphoramidates: A design of experiment approach
Maurício Carpe Diem Ferreira Xavier, Daniela Hartwig, Livia Conceição Lima Valente, et al.
Tetrahedron (2022) Vol. 120, pp. 132879-132879
Closed Access | Times Cited: 5

Identification and semisynthesis of (−)-anisomelic acid as oral agent against SARS-CoV-2 in mice
Hai‐Xin Yu, Nan Zheng, Chi‐Tai Yeh, et al.
National Science Review (2022) Vol. 9, Iss. 11
Open Access | Times Cited: 4

Enzymatic Catalysts to Combat COVID-19
Isita Jhulki, Jordan L. Meier
ACS Central Science (2021) Vol. 7, Iss. 12, pp. 1963-1965
Open Access | Times Cited: 4

Preparing anti-SARS-CoV-2 agent EIDD-2801 by a practical and scalable approach, and quick evaluation via machine learning
Zhen Qin, Bin Dong, Renbing Wang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3678-3682
Open Access | Times Cited: 2

Page 1

Scroll to top